Related Experiment Videos

Hepatic steatosis: a frequent non-specific finding in HIV-infected children

M Albisetti1, C P Braegger, T Stallmach

  • 1University Children's Hospital of Zürich, Infectious Diseases Unit, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland.

Insights

Hepatic steatosis (fatty liver) is common in children with human immunodeficiency virus (HIV) infection. This condition is non-specific and does not impact disease management, making ultrasonography a reliable screening tool.

Area of Science:

  • Pediatrics
  • Hepatology
  • Infectious Diseases

Background:

  • Human immunodeficiency virus (HIV) infection can affect multiple organ systems.
  • Hepatic abnormalities are a known complication in HIV-infected individuals.
  • The prevalence and impact of hepatic steatosis in pediatric HIV are not well-defined.

Purpose of the Study:

  • To investigate the prevalence of morphologic hepatic abnormalities in HIV-infected children.
  • To evaluate the utility of ultrasonography in detecting hepatic steatosis in this population.
  • To determine the association between hepatic steatosis and HIV infection stage.

Main Methods:

  • Cross-sectional study involving 30 HIV-infected children.
  • Abdominal ultrasonography performed in 27 children to assess liver structure.
  • Liver histology performed in 11 children for confirmation of steatosis.
  • Patients categorized based on HIV infection stage (N, A, B, C).

Main Results:

  • Abnormal liver structure, consistent with hepatic steatosis, was detected in 85% of children via ultrasonography.
  • Histological examination confirmed steatosis in 91% of biopsied children, with 70% previously suspected by ultrasound.
  • Steatosis was observed across all stages of HIV infection, with a higher prevalence in category C.

Conclusions:

  • Hepatic steatosis is a common finding in HIV-infected children.
  • Ultrasonography is a sensitive, accurate, and non-invasive method for screening hepatic steatosis.
  • The presence of steatosis in this cohort appears non-specific and does not influence disease management.

Related Concept Videos